Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Mar 14, 2013 · 10-K · 73 days after period end · 0001144204-13-014932
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$2.24M | -$5.00M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 14, 2013 · 73 d after period end
